Evidence map›Paper›PMID 42713326›Full record

ArticleAdvances in laboratory medicine2026

A machine-learning capillary electrophoresis-based pattern to identify suspected sickle cell trait and α-thalassemia co-inheritance.

David Ceacero-Marín, Anna Cortés Bosch de Basea, Isabel Puig-Pey Comas, Mónica Vidal Pla, Lourdes Sánchez Navarro

Abstract read
In one paragraph

Article in Advances in laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David Ceacero-MarínClinical Laboratory, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.ORCID https://orcid.org/0009-0008-8494-4565
Anna Cortés Bosch de BaseaClinical Laboratory, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Isabel Puig-Pey ComasClinical Laboratory, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Mónica Vidal PlaClinical Laboratory, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Lourdes Sánchez NavarroClinical Laboratory, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Sickle cell trait (HbAS) and α-thalassemia are common conditions. Although their hematological laboratory findings have been extensively characterized individually, there is limited evidence on the hematological pattern when they are co-inherited. Early and simple diagnosis of HbAS/α-thalassemia allows for optimization of the clinical approach and provision of appropriate genetic counselling. The objective is to identify, using machine learning algorithms, the most relevant hematological quantities and to establish a useful cut-off value for screening patients with suspected HbAS/α-thalassemia. Methods: A database containing 235 patients carrying HbAS was obtained from the laboratory information system. The following variables were collected: hemoglobin and erythrocytes concentration, mean corpuscular volume (MCV), and the fractions of hemoglobin S (%HbS), A (%HbA), A2 and F. A multivariate clustering analysis was performed using the k-means algorithm to divide the dataset into two subgroups: HbAS and suspected HbAS/α-thalassemia. ROC curve was constructed for each variable to identify patients with suspected HbAS/α-thalassemia. Results: Patients with %HbS <37.6 % and %HbA >59 % were classified as suspected HbAS/α-thalassemia with 100 % sensitivity, 97.7 % specificity and AUC [95 % CI] of 0.989 [0.977-0.997]. Patients with suspected HbAS/α-thalassemia exhibited significantly lower hemoglobin concentrations (p=0.008), MCV (p<0.001) and %HbS (p<0.001). In contrast, significantly higher erythrocyte concentrations and %HbA (p<0.001) were observed, compared to HbAS alone. Conclusions: The proposed discriminant values enable suspected cases of HbAS/α-thalassemia to be identified. This facilitates the prioritization of genetic testing for α-thalassemia to be conducted, the provision of genetic and family counselling, and the risk to be accurately assessed for these patients.

Indexed as

alpha-thalassemiaanemiasickle cellsickle cell traitthalassemia

Identifiers

PMID42713326
PMCPMC13552811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.